http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-19980702239-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
filingDate 1996-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1998-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-19980702239-A
titleOfInvention Formulations for transdermal administration
abstract The present invention relates to muscarinic receptor regulation using 3- [4- (butylthio) -1,2,5-thiadiazol-3-yl] -1-azabicyclo [2.2.2] octane transdermal formulation. It provides a method for treating an associated disease. The present invention provides 3- [4- (butylthio) -1,2,5-thiadiazol-3-yl] -1-azabicyclo [2.2.2] octane patch formulations for desired transdermal administration.
priorityDate 1995-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414021757
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502596
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419488112
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID356
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416290180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19427205
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407124392
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID42981
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5283468
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415725302
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60868
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419499210
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4848
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410

Total number of triples: 38.